The Latest Breaking News from Cancer

Personalized mRNA Cancer Vaccine Shows Five-Year Data Stunning Oncologists with 69 Percent of Stage III IV Melanoma Patients Cancer-Free

ASCO 2026 (June 3, 2026) and Journal of Clinical Oncology: Intismeran autogene + Keytruda shows 49% sustained recurrence reduction at 5 years, 59% distant metastasis reduction, and 53% overall survival benefit in high-risk Stage III/IV melanoma. 69% of combination patients are cancer-free at 5 years.

Medical Daily · Jun 16

Phase 3 Trial Confirms Exercise Can Reverse Chemo Brain, Easing Cognitive Impairment Affecting 80 Percent of Cancer Patients

A Phase 3 EXCAP trial published in June 2026 demonstrates that a structured home-based walking exercise program significantly reduces chemotherapy-induced cognitive impairment (chemo brain) in cancer patients. Up to 80% of chemotherapy patients experience chemo brain, which can persist for years. Here is the full finding.

Medical Daily · Jun 16

Scary Movie's Cheri Oteri has undergone surgery for breast cancer

Scary Movie star Cheri Oteri recently had a second lumpectomy after being diagnosed with ductal carcinoma in situ (DCIS), a "very early form" of breast cancer.

BANG Premier · Jun 15

Who is Leah Stewart? Coogee shark attack victim identified as accomplished swimmer and young mother who raised funds for breast cancer research

Leah Stewart, a 35-year-old open-water swimmer and mother, was critically injured in a shark attack off Coogee Beach. She was reportedly mauled by a great white shark while swimming approximately 30 meters offshore. Stewart, known for her fundraising efforts for breast cancer research, is in critical but stable condition.

The Economic Times · Jun 15

‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?

Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterrorism, pandemic preparedness and cancer treatment.

Euronews · Jun 15

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

FLORENCE, Italy and NEW YORK, June 14, 2026 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, announced that new data related to the pivotal…

AAP · Jun 14

Tata Trusts to hike philanthropic spending to Rs 2,000 cr this fiscal, CEO hits back at 'chaos' narrative

Tata Trusts will boost its charitable spending to Rs 2,000 crore this fiscal year. CEO Siddharth Sharma highlighted the trusts' commitment to societal upliftment. This increased funding will support initiatives like cancer care and the establishment of a new university and hospital. Sharma emphasized the trusts' ongoing dedication to their…

The Economic Times · Jun 14

London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’

Poolbeg Pharma to test the treatment in NHS hospitals and says it is also developing a GLP-1 weight loss pill

The Guardian - UK · Jun 14

NHS staff battling wave of food supplement disinformation

Exclusive: Cancer charity says dispelling falsehoods gleaned from social media is now routine task for clinicians

The Guardian - UK · Jun 14

Behind the World Cup video bringing young people together in Dundee

A NEW video to celebrate the start of the men’s football World Cup and promote protection against skin cancer has brought young people together in…

The National (Scotland) · Jun 14